UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 111

Sortiert nach

Quality Controls of Immune Regulatory Properties of Ex-Vivo, GMP-Grade Expanded Mesenchymal Stromal Cells for Clinical Use (European multicenter study CASCADE)

Blood, 2011-11, Vol.118 (21), p.4049-4049

2011

Volltextzugriff (PDF)

Microporous Biphasic Calcium Phosphate Granules (MBCP®) Retain Immunological Properties of Bone Marrow-Derived Mesenchymal Stromal Cells and Promote Osteoblastic Differentiation

Blood, 2011-11, Vol.118 (21), p.1924-1924

2011

Volltextzugriff (PDF)

Proof of Concept of an Assistive Robotic Arm Control Using Artificial Stereovision and Eye-Tracking

IEEE transactions on neural systems and rehabilitation engineering, 2019-12, Vol.27 (12), p.2344-2352

2019

Volltextzugriff (PDF)

Integrated transcriptomic, phenotypic, and functional study reveals tissue‐specific immune properties of mesenchymal stromal cells

Stem cells (Dayton, Ohio), 2020-01, Vol.38 (1), p.146-159

2020

Volltextzugriff (PDF)

Behavior Change Techniques in Popular Mobile Apps for Smoking Cessation in France: Content Analysis

JMIR mHealth and uHealth, 2021-05, Vol.9 (5), p.e26082-e26082

2021

Volltextzugriff (PDF)

NK cell activation and recovery of NK cell subsets in lymphoma patients after obinutuzumab and lenalidomide treatment

Oncoimmunology, 2018-04, Vol.7 (4), p.e1409322-e1409322

2018

Volltextzugriff (PDF)

Alternatively spliced NKp30 isoforms affect the prognosis of gastrointestinal stromal tumors

Nature Medicine, 2011-06, Vol.17 (6), p.700-707

2011

Volltextzugriff (PDF)

Pulmonary alveolar proteinosis

Respirology (Carlton, Vic.), 2020-08, Vol.25 (8), p.816-826

2020

Volltextzugriff (PDF)

Axicabtagene Ciloleucel As Second-Line Therapy for Large B-Cell Lymphoma in Transplant-Ineligible Patients: Primary Analysis of Alycante, a Phase 2 Lysa Study

Blood, 2022-11, Vol.140 (Supplement 1), p.410-411

2022

Volltextzugriff (PDF)

A novel dendritic cell subset involved in tumor immunosurveillance

Nature Medicine, 2006-02, Vol.12 (2), p.214-219

2006

Volltextzugriff (PDF)

Mechanically isolated stromal vascular fraction provides a valid and useful collagenase-free alternative technique: A comparative study

Plastic and reconstructive surgery (1963), 2017-02, Vol.139 (2), p.572e-573e

Ménard, Cédric

2017

Volltextzugriff (PDF)

Rituximab for auto-immune alveolar proteinosis, a real life cohort study

Respiratory research, 2018-04, Vol.19 (1), p.74-74, Article 74

2018

Volltextzugriff (PDF)

Mesenchymal stromal cells orchestrate follicular lymphoma cell niche through the CCL2-dependent recruitment and polarization of monocytes

Blood, 2012-03, Vol.119 (11), p.2556-2567

2012

Volltextzugriff (PDF)

The role of regulatory T cells in the control of natural killer cells: relevance during tumor progression

Immunological reviews, 2006-12, Vol.214 (1), p.229-238

2006

Volltextzugriff (PDF)

Immunoregulatory properties of clinical grade mesenchymal stromal cells: evidence, uncertainties, and clinical application

Stem cell research & therapy, 2013-06, Vol.4 (3), p.64-64, Article 64

2013

Volltextzugriff (PDF)

Natural Killer Cell IFN-γ Levels Predict Long-term Survival with Imatinib Mesylate Therapy in Gastrointestinal Stromal Tumor-Bearing Patients

Cancer research (Chicago, Ill.), 2009-04, Vol.69 (8), p.3563-3569

2009

Volltextzugriff (PDF)

Cancer chemotherapy: not only a direct cytotoxic effect, but also an adjuvant for antitumor immunity

Cancer Immunology, Immunotherapy, 2008-11, Vol.57 (11), p.1579-1587

2008

Volltextzugriff (PDF)

Brief Report: Proteasomal Indoleamine 2,3‐Dioxygenase Degradation Reduces the Immunosuppressive Potential of Clinical Grade‐Mesenchymal Stromal Cells Undergoing Replicative Senescence

Stem cells (Dayton, Ohio), 2017-05, Vol.35 (5), p.1431-1436

2017

Volltextzugriff (PDF)

CTLA-4 Blockade Confers Lymphocyte Resistance to Regulatory T-Cells in Advanced Melanoma: Surrogate Marker of Efficacy of Tremelimumab?

Clinical cancer research, 2008-08, Vol.14 (16), p.5242-5249

2008

Volltextzugriff (PDF)

An open-label phase 1b study of obinutuzumab plus lenalidomide in relapsed/refractory follicular B-cell lymphoma

Blood, 2018-10, Vol.132 (14), p.1486-1494

2018

Volltextzugriff (PDF)

Dendritic cells and innate defense against tumor cells

Cytokine & growth factor reviews, 2008-02, Vol.19 (1), p.79-92

2008

Volltextzugriff (PDF)

Therapist-Reported Differences between Teletherapy via Phone and via Videoconferencing

Brain sciences, 2023-12, Vol.13 (12), p.1714

2023

Volltextzugriff (PDF)

1 – 25 von 111

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(108)
Mit Volltextzugriff
(100)

Publikationsform

Artikel
(110)
Buchkapitel
(1)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Quality Controls of Immune Regulatory Properties of Ex-Vivo, GMP-Grade Expanded Mesenchymal Stromal Cells for Clinical Use (European multicenter study CASCADE)

Microporous Biphasic Calcium Phosphate Granules (MBCP®) Retain Immunological Properties of Bone Marrow-Derived Mesenchymal Stromal Cells and Promote Osteoblastic Differentiation

Proof of Concept of an Assistive Robotic Arm Control Using Artificial Stereovision and Eye-Tracking

Integrated transcriptomic, phenotypic, and functional study reveals tissue‐specific immune properties of mesenchymal stromal cells

Behavior Change Techniques in Popular Mobile Apps for Smoking Cessation in France: Content Analysis

NK cell activation and recovery of NK cell subsets in lymphoma patients after obinutuzumab and lenalidomide treatment

Alternatively spliced NKp30 isoforms affect the prognosis of gastrointestinal stromal tumors

Infections in autoimmune pulmonary alveolar proteinosis: a large retrospective cohort

Pulmonary alveolar proteinosis

Axicabtagene Ciloleucel As Second-Line Therapy for Large B-Cell Lymphoma in Transplant-Ineligible Patients: Primary Analysis of Alycante, a Phase 2 Lysa Study

A novel dendritic cell subset involved in tumor immunosurveillance

Mechanically isolated stromal vascular fraction provides a valid and useful collagenase-free alternative technique: A comparative study

Rituximab for auto-immune alveolar proteinosis, a real life cohort study

Mesenchymal stromal cells orchestrate follicular lymphoma cell niche through the CCL2-dependent recruitment and polarization of monocytes

The role of regulatory T cells in the control of natural killer cells: relevance during tumor progression

Immunoregulatory properties of clinical grade mesenchymal stromal cells: evidence, uncertainties, and clinical application

Natural Killer Cell IFN-γ Levels Predict Long-term Survival with Imatinib Mesylate Therapy in Gastrointestinal Stromal Tumor-Bearing Patients

P1123: EARLY CTDNA CLEARANCE AFTER CAR T‐CELL INFUSION PREDICTS OUTCOME IN PATIENTS WITH LARGE B‐CELL LYMPHOMA: RESULTS FROM ALYCANTE, A PHASE 2 LYSA STUDY

Cancer chemotherapy: not only a direct cytotoxic effect, but also an adjuvant for antitumor immunity

S233: AXICABTAGENE CILOLEUCEL AS SECOND‐LINE THERAPY FOR LARGE B‐CELL LYMPHOMA IN TRANSPLANT‐INELIGIBLE PATIENTS: FINAL ANALYSIS OF ALYCANTE, A PHASE 2 LYSA STUDY

Brief Report: Proteasomal Indoleamine 2,3‐Dioxygenase Degradation Reduces the Immunosuppressive Potential of Clinical Grade‐Mesenchymal Stromal Cells Undergoing Replicative Senescence

CTLA-4 Blockade Confers Lymphocyte Resistance to Regulatory T-Cells in Advanced Melanoma: Surrogate Marker of Efficacy of Tremelimumab?

An open-label phase 1b study of obinutuzumab plus lenalidomide in relapsed/refractory follicular B-cell lymphoma

Dendritic cells and innate defense against tumor cells

Therapist-Reported Differences between Teletherapy via Phone and via Videoconferencing

Suchergebnisse filtern